Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cytodyne sues New York Times

This article was originally published in The Tan Sheet

Executive Summary

Lawsuit filed in Newark, N. J. federal court June 24 by former Xenadrine marketer alleges New York Times reporter Ford Fessenden "selectively excluded scientific information regarding clinical testing performed" on Xenadrine in June 23 article on dietary supplements. Complaint alleges Fessenden failed to contact Cytodyne for clarification and "accepted only a one-sided, inaccurate and untruthful version of the 'facts.'" Suit refers to recent controversy involving reporter Jayson Blair and alleges newspaper has "engaged in a pattern of failing to supervise its reporters and failing to check the accuracy and completeness" of stories. In response, Times says it is "confident" in the accuracy of its article, "which was based on court records and judicial decisions"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095628

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel